Cargando…
Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
Ferroptosis is an iron‐dependent, lipid peroxide‐driven cell death caused by inhibition of the cystine/glutamate transporter, which is of importance for the survival of triple‐negative breast cancer (TNBC) cells. Erastin is a low molecular weight chemotherapy drug that induces ferroptosis; however,...
Autores principales: | Yu, Mengyu, Gai, Chengcheng, Li, Zihaoran, Ding, Dejun, Zheng, Jie, Zhang, Weifen, Lv, Shijun, Li, Wentong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778638/ https://www.ncbi.nlm.nih.gov/pubmed/31464035 http://dx.doi.org/10.1111/cas.14181 |
Ejemplares similares
-
Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer
por: Li, Zihaoran, et al.
Publicado: (2021) -
MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells
por: Gai, Chengcheng, et al.
Publicado: (2020) -
Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
por: Zhang, Weifen, et al.
Publicado: (2018) -
How erastin assassinates cells by ferroptosis revealed
por: Gan, Boyi
Publicado: (2022) -
Arginine Expedites Erastin-Induced Ferroptosis through Fumarate
por: Guo, Xinxin, et al.
Publicado: (2023)